Besifloxacin Ophthalmic Suspension: Emerging Evidence of its Therapeutic Value in Bacterial Conjunctivitis

OBJECTIVE: To outline the pharmacodynamics, efficacy and safety of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. QUALITY OF EVIDENCE: MEDLINE database was searched to review recent pharmacodynamic and clinical studies evaluating besifloxacin and comparing besi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khimdas, S., Visscher, K.L., Hutnik, C.M.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661456/
https://www.ncbi.nlm.nih.gov/pubmed/23861618
http://dx.doi.org/10.4137/OED.S4102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661456/
https://www.ncbi.nlm.nih.gov/pubmed/23861618
http://dx.doi.org/10.4137/OED.S4102

Ejemplares similares